Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Grant Dixon is an associate in the firm’s Washington, DC office, where he is a member of the Food, Drug, and Device group. He advises food, device, pharmaceutical, and biotechnology companies on a variety of regulatory and compliance issues.

  • Counseled businesses on issues of drug and medical device approval, and on Hatch-Waxman exclusivity strategies.
  • Represented industry association in submission of public comments to FDA.
  • Prepared citizen petition for innovative company concerning bioequivalence methods related to ANDA approval.
  • Advised businesses of regulatory risks associated with the purchase of medical device and animal health companies.